ZACHARY AND ELIZABETH M FISHER CENTER FOR ALZHEIMERS RESEARCH FDN: Form 990, tax year 2020

View the entire original 990 at ProPublica ↗

Organization
ZACHARY AND ELIZABETH M FISHER CENTER FOR ALZHEIMERS RESEARCH FDN (EIN 13-3859563)
Tax period
2020-01-01 to 2020-12-31
Filed
2021-11-15
IRS object ID
202133199349327463
Schema version
2020v4.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2021-11-15T18:50:10-06:00ReturnTs
Tax Period End2020-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN271728945PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1PKF O'CONNOR DAVIES LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1500 MAMARONECK AVENUEAddressLine1Txt
CityHARRISONCityNm
State AbbreviationNYStateAbbreviationCd
ZIP105281633ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2020-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN133859563EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1THE ZACHARY & ELIZABETH M FISHER CENTERBusinessNameLine1Txt
Business Name Line2FOR ALZHEIMER'S RESEARCH FOUNDATIONBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlZACHBusinessNameControlTxt
Phone2129151328PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1FDR STATION PO BOX 220AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10150ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonBARRY R SLOANEPersonNm
Person TitleCHAIRMAN & TREASURERPersonTitleTxt
Phone2129151328PhoneNum
Signature2021-11-15SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstBARRYPersonFirstNm
Person LastSLOANEPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonGARRETT M HIGGINSPreparerPersonNm
PTINP00543209PTIN
Phone9143818900PhoneNum
Preparation2021-11-15PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2020TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1ALZHEIMER'S RESEARCH FOUNDATIONFISHER CENTERBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerBARRY R SLOANEPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1FDR STATION PO BOX 220AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10150ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$13,602,731GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.ALZINFO.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1995FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or MissionTHE FOUNDATION FUNDS RESEARCH INTO THE CAUSE, CARE, AND CURE OF ALZHEIMER'S DISEASE AT THE ZACHARY AND ELIZABETH M. FISHER CENTER FOR RESEARCH ON ALZHEIMER'S DISEASE AT THE ROCKEFELLER UNIVERSITY IN NEW YORK THAT WAS UNDER THE DIRECTION OF NOBEL LAUREATE DR. PAUL GREENGARD WHOSE FINDINGS HAVE BEEN THE BASIS FOR MUCH OF TODAY'S ALZHEIMER'S INVESTIGATIONS.ActivityOrMissionDesc
Voting Members Governing Body12VotingMembersGoverningBodyCnt
Voting Members Independent11VotingMembersIndependentCnt
Total Employee4TotalEmployeeCnt
Total Volunteers13TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$6,868,429PYContributionsGrantsAmt
CY Contributions Grants$7,458,789CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$2,253,116PYInvestmentIncomeAmt
CY Investment Income$2,536,517CYInvestmentIncomeAmt
PY Other Revenue$3,000PYOtherRevenueAmt
CY Other Revenue$385CYOtherRevenueAmt
PY Total Revenue$9,124,545PYTotalRevenueAmt
CY Total Revenue$9,995,691CYTotalRevenueAmt
PY Grants And Similar Paid$3,430,534PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$4,959,013CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$742,488PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$587,743CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$384,270CYTotalFundraisingExpenseAmt
PY Other Expenses$501,354PYOtherExpensesAmt
CY Other Expenses$1,030,154CYOtherExpensesAmt
PY Total Expenses$4,674,376PYTotalExpensesAmt
CY Total Expenses$6,576,910CYTotalExpensesAmt
PY Revenues Less Expenses$4,450,169PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$3,418,781CYRevenuesLessExpensesAmt
Total Assets BOY$31,521,960TotalAssetsBOYAmt
Total Assets EOY$34,799,750TotalAssetsEOYAmt
Total Liabilities BOY$2,890,733TotalLiabilitiesBOYAmt
Total Liabilities EOY$2,445,530TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$28,631,227NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$32,354,220NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE ZACHARY AND ELIZABETH M. FISHER CENTER FOR ALZHEIMER'S RESEARCH FOUNDATION IS DEDICATED TO ATTACKING THE SCOURGE OF ALZHEIMER'S DISEASE THROUGH A 3-PRONGED ASSAULT FOCUSED ON UNDERSTANDING THE CAUSE OF ALZHEIMER'S DISEASE (AD), IMPROVING THE CARE OF PEOPLE LIVING WITH THE DISEASE TO ENHANCE THEIR QUALITY OF LIFE AND THAT OF THEIR CAREGIVERS AND FAMILIES, AND FINDING A CURE.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$4,059,013ExpenseAmt
Grant$4,059,013GrantAmt
DescA MAJORITY OF OUR GRANT FUNDING GOES TO THE ZACHARY AND ELIZABETH M. FISHER CENTER FOR RESEARCH ON ALZHEIMER'S DISEASE (THE FISHER CENTER LAB) AT THE ROCKEFELLER UNIVERSITY IN NEW YORK FOR NEUROLOGICAL RESEARCH INTO THE CAUSE OF ALZHEIMER'S AND POTENTIAL NEW PHARMACOLOGICAL TREATMENT OPTIONS. THE LAB IS UNDER THE INTERIM DIRECTION OF DR. MARC FLAJOLET SINCE THE PASSING OF NOBEL LAUREATE DR. PAUL GREENGARD IN 2019. THE FISHER CENTER PROVIDES RESEARCHERS WORLDWIDE WITH A CONCEPTUAL FRAMEWORK FOR UNDERSTANDING THE DISEASE PROCESS, AND CONTINUES TO BE AT THE FOREFRONT OF ONE DAY FINDING A CURE FOR ALZHEIMER'S DISEASE. DURING THE CALENDAR YEAR RESEARCHERS DISCOVERED THAT SPECIFIC TYPES OF NERVE CELLS (NEURONS) ARE MORE SUSCEPTIBLE TO THE ALZHEIME'S DISEASE PATHOLOGY, BEING AFFECTED AND DISAPPEARING SOONER THAN OTHER NEURONS (RESISTANT). FISHER SCIENTISTS ARE USING A UNIQUE SET OF TECHNOLOGIES TO BETTER UNDERSTAND UNDERLYING CAUSES OF THIS PROCESS AND HELP DESIGN ENTIRELY NEW THERAPEUTIC STRATEGIES. NEW GENES ARE BEING CHARACTERIZED THAT THEY HAVE LINKED TO VULNERABILITY. A SECOND RELATIVELY NEW PROJECT IS CENTERED ON OUR DISCOVERY THAT A DIFFERENT FRAGMENT OF APP (CALLED C99) IS A BETTER MARKER FOR NEURODEGENERATION. THIS STUDY WAS MOSTLY BASED ON HUMAN BRAIN SAMPLES WHICH GIVES IT EVEN MORE VALUE. IN OTHER RESEARCH, THE SCIENTISTS ACCELERATED THE BREAKDOWN OF THE TOXIC BETA-AMYLOID COMPONENT BY TARGETING A CELLULAR PROCESS CALLED AUTOPHAGY, A PROCESS RESPONSIBLE FOR REMOVING DEBRIS FROM THE CELLS. THE SCIENTISTS IDENTIFIED A NOVEL SIGNALING NETWORK WITHIN NEURONS THAT REGULATES BETA-AMYLOID DEGRADATION. SCIENTISTS CONTINUE TO DEVELOP THERAPEUTIC APPROACHES AND BUILD A NOVEL PLATFORM FOR DRUG DISCOVERY APPLICATIONS AS THEY CHARACTERIZE AND OPTIMIZE CHEMICALLY ACTIVE MOLECULES. ONE MOLECULE IDENTIFIED MIGHT HELP PROTECT PEOPLE FROM DEVELOPING ALZHEIMER'S DISEASE.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$785,304ExpenseAmt
DescTHE ALZHEIMER'S INFORMATION PROGRAM PROMOTES PUBLIC DISEASE AWARENESS, EDUCATION, AND RESOURCES FOR CAREGIVERS (AND PATIENTS) THROUGH MEDIA CONDUITS, SOCIAL NETWORKS, AND THE INTERNET. THE HEART OF THE PROGRAM IS THE WEBSITE, ALZINFO.ORG, WHICH IS UPDATED REGULARLY TO PROVIDE COMPREHENSIVE DATA ABOUT ALZHEIMER'S DISEASE, RECENT RESEARCH STUDIES AND FINDINGS, TREATMENT AND DISEASE MANAGEMENT. THE SITE HAD 433,760 UNIQUE VISITORS AND OFFERS A FREE RESOURCE LOCATOR THAT IDENTIFIES DOCTORS, NURSES, GERIATRIC CAREGIVERS, HOME HEALTH AGENCIES AND OTHER SOURCES BY ZIP CODE. OUR SCIENTISTS ANSWER QUESTIONS THROUGH "ASK THE EXPERTS" PORTAL ON OUR WEBSITE, AND CAREGIVERS CAN JOIN OUR SUPPORT GROUP THROUGH OUR ONLINE CAREGIVER'S CORNER. OUR 1-800-ALZ-INFO PHONE SYSTEM ASSISTS PEOPLE WHO DO NOT HAVE ACCESS TO THE INTERNET. OUR SCIENTISTS ANSWER QUESTIONS THROUGH THE "ASK THE EXPERTS" FEATURE ON OUR WEBSITE; OUR FREE E-NEWSLETTER, ALZHEIMER'S RESEARCH NEWS YOU CAN USE, IS THE MOST REVIEWED ALZHEIMER'S AND DEMENTIA NEWSLETTER ON THE INTERNET; AND CAREGIVERS CAN JOIN OUR SUPPORT GROUP THROUGH OUR ONLINE CAREGIVER'S CORNER. OUR 1-800-ALZ-INFO PHONE SYSTEM ASSISTS PEOPLE WHO DO NOT HAVE ACCESS TO THE INTERNET. OUR AWARD-WINNING TRI-ANNUAL PRINT PUBLICATION (PRESERVING YOUR MEMORY) CIRCULATES 51,500 COPIES PER ISSUE, WITH AN ESTIMATED READERSHIP OF 772,500. THE EDITORIAL CONTENT IS REVIEWED BY OUR SCIENTIFIC TEAM FOR ACCURACY AND VALIDITY AS IT ADDRESSES CONCERNS OF READERS AFFECTED BY THE DISEASE (WHETHER CAREGIVER OR PATIENT), AND PROVIDES INFORMATION ABOUT ALZHEIMER'S TREATMENT, CARE OPTIONS, AND HOW TO TAKE THE NECESSARY STEPS TO ADEQUATELY PREPARE IF THEY, OR SOMEONE THEY LOVE, RECEIVE(S) AN ALZHEIMER'S DIAGNOSIS.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$750,000ExpenseAmt
Grant$750,000GrantAmt
DescDURING THE PANDEMIC, THE FISHER CENTER LAB AT THE ROCKEFELLER UNIVERSITY CAMPUS WAS PART OF AN ORGANIZED COLLECTION OF MEDICAL ITEMS INCLUDING BOXES OF GLOVES, MASKS, HARD FACE SHIELDS AND LAB GOGGLES TO PROVIDE TO HOSPITALS IN NEED. IN ADDITION, ONE LARGE EFFORT THAT THE FISHER CENTER LAB SCIENTISTS TOOK OVER THE LAST YEAR AND A HALF WAS TO BUILD A TOTALLY NOVEL DRUG DISCOVERY PLATFORM THAT WILL CONSIDERABLY SPEED UP THE DRUG DISCOVERY PROCESS FOR ALZHEIMER'S DISEASE. DUE TO THE URGENT NEEDS FOR NEW DRUGS FOR THE CORONAVIRUS, DR. FLAJOLET AND THE ROCKEFELLER UNIVERSITY LEADERS IMMEDIATELY IDENTIFIED THAT SOME OF THE SCIENTIFIC KNOWLEDGE AT THE FISHER CENTER LAB COULD BE USED TO HELP WITH COVID-19 EFFORTS. OUR TEAM OF SCIENTISTS DILIGENTLY WORKED LONG HOURS, SEVEN DAYS A WEEK, IN MARCH AND APRIL TO BRING THE SCREENING PLATFORM TO A FUNCTIONAL LEVEL, AND IT IS NOW READY FOR DRUG DISCOVERY. ADDITIONALLY, THE FISHER CENTER LAB TEAM WORKED ON TWO PROTEINS OF COVID-19 THAT BELONG TO A FAMILY OF PROTEINS THAT THEY UNDERSTAND VERY WELL. THEY WILL ALSO MAKE THEIR DRUG DISCOVERY PLATFORM AVAILABLE TO OTHER SCIENTISTS WORKING ON OTHER PROTEIN TARGETS OF COVID-19.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
Expense$150,000ExpenseAmt
Grant$150,000GrantAmt
DescA GRANT WAS GIVEN TO THE BRAIN AND SPINE IMAGING INSTITUTE TO CARRY OUT RESEARCH BY BENOIT DELATOUR, MARC DHENAIN, PATRICE DUBREUIL, AND OLIVIER HERMINE TO INVESTIGATE WHETHER STRUCTURE OF AMYLOID PROTEINS ARE CHANGED PARTICULARLY IF PROTEINS AGGREGATES, WHICH ARE TOXIC FOR SYNAPSES, ARE DECREASED. IN THIS HYPOTHESIS, MASITINIB MAY DECREASE PROTEASE RELEASE BY MAST CELLS, WHICH MAY BE RESPONSIBLE FOR GENERATION OF PROTEINS AGGREGATE, AND TEST WHETHER MASITINIB IS ABLE TO BLOCK LESIONS SPREADING AFTER PRIONS LIKE PROTEINS INOCULATION. THIS PROJECT WILL REVEAL ROLE OF MAST CELL AND KINASES IN THE PATHOPHYSIOLOGY OF ALZHEIMER DISEASE. A BETTER UNDERSTANDING OF ITS MECHANISMS MAY DEFINE THE BEST STRATEGY TO IMPROVE ALZHEIMER'S DISEASE. THE TEAM REPORTED THAT MASITINIB IS A DRUG-LIKE COMPOUND WHICH INHIBITS A TYPE OF SIGNALING PROTEIN CALLED A KINASE. KINASES ARE IMPORTANT REGULATORS OF CELLULAR COMMUNICATION. INITIALLY, MASITINIB HAS BEEN SHOWN TO SPECIFICALLY BLOCK THE ACTIVITY OF THREE SUCH KINASES: C-KIT, LYN AND FYN. THESE ARE IMPORTANT FOR A TYPE OF CELLS CALLED MAST CELLS. SIGNALING OF MAST CELLS PLAY A CRUCIAL ROLE FOR THE IMMUNE SYSTEM AND THE BRAIN. MASITINIB HAS ALSO BEEN SHOWN TO TARGET ANOTHER KINASE CALLED MCSFR-1 THAT PLAYS A CRITICAL ROLE IN MICROGLIA MODULATION. MICROGLIA IS A TYPE OF CELL THAT HAS A SCAVENGER FUNCTION IN THE BRAIN AND IS BELIEVED TO BE HIGHLY RELEVANT FOR AD. IN SUMMARY, MASITINIB COULD ACT ON FOUR DIFFERENT TARGETS THAT INVOLVE DYSFUNCTIONAL MECHANISMS IN AD: MODULATION OF MICROGLIA, PROTECTION OF SYNAPSES, INHIBITION OF TAU PROTEIN, AND CONTROL OF MAST CELL ACTIVITY. IN ONE EXPERIMENT (THE MORRIS WATER MAZE TEST), A MOUSE MODEL OF ALZHEIMER'S DISEASE WAS USED AND COMPARED TO NORMAL MICE. THE TEST MEASURED THE ABILITY OF MICE TO MEMORIZE THE LOCATION OF A SMALL SUBMERGED PLATFORM IN A POOL OF MILKY WATER. AFTER SEVERAL ATTEMPTS, NORMAL MICE MEMORIZE THE LOCATION OF THE PLATFORM, LOCATING THE SUBMERGED PLATFORM QUICKLY, WHILE AD MICE WERE SIGNIFICANTLY SLOWER. MASITINIB SIGNIFICANTLY IMPROVED THE COGNITIVE ABILITY IN AD MICE IN THIS TEST. SIMILARLY, MASITINIB COULD PROTECT AGAINST SYNAPTIC LOSS (THE ACTIVE ZONES BETWEEN NEURONS WHICH ARE CRUCIAL FOR NEURONAL COMMUNICATION) BY REDUCING MAST CELL ACTIVITY. IN A NOVEL CLINICAL TRIAL, THREE VARYING DOSES OF MASITINIB WERE TESTED ON AD PATIENTS: 3 MG/KG/DAY, 4.5 MG/KG/DAY AND TITRATION FROM 4.5 TO 6 MG/KG/DAY. EARLY ON, THE STUDY ARM INVOLVING THE LOWER DOSE WAS STOPPED. THE STUDY ENROLLED 718 PATIENTS FROM 118 SITES IN 21 COUNTRIES. THE LATEST RESULTS REPORTED CORRESPOND TO 24 WEEKS OF TREATMENT. SIGNIFICANT EFFECTS WERE OBSERVED IN THE AREAS OF COGNITIVE FUNCTION, DAILY ACTIVITY, AND 71% IMPROVEMENT ON CIBIC, AS WELL AS SOME NUMERICAL ADVANTAGES (NOT STATISTICALLY SIGNIFICANT) OF MASITINIB ON OTHER TESTS (MMSE, CDR AND NPI). FROM THOSE ENCOURAGING STUDIES, IT IS POSSIBLE TO CONCLUDE THAT 4.5 MG/KG/DAY REPRESENTS THE EFFECTIVE DOSE FOR AD.A GRANT WAS MADE TO THE NEW YORK UNIVERSITY SCHOOL OF MEDICINE FOR THE FISHER ALZHEIMER'S DISEASE EDUCATION AND RESOURCES PROGRAM WHERE DRS. REISBERG AND KENOWSKY EXAMINED HEALTH OUTCOMES OF THE COMPREHENSIVE,INDIVIDUALIZED, PATIENT CENTERED ALZHEIMER'S MANAGEMENT PROGRAM.PRIMARY RESEARCH FOCUSED ON THE EFFECTS OF THE PROGRAM ON ANTIDEPRESSANT USAGE AND COST. PREVIOUSLY THEY DESCRIBED THE STAGES OF ALZHEIMER'S DISEASE (AD) THAT IMPROVED WORLDWIDE UNDERSTANDING OF AD AND ASSISTED IN THE DISCOVERY OF NEW TREATMENTS FOR AD. FOR EXAMPLE, A STAGE OF "MILD COGNITIVE IMPAIRMENT," (MCI) PRIOR TO THE ADVENT OF THE DEMENTIA OF AD AND A STAGE OF "SUBJECTIVE COGNITIVE DECLINE" (SCD) WHICH OCCURS PRIOR TO THE MCI STAGE. BOTH OF THESE STAGES HAVE SUBSEQUENTLY BECOME "HOUSEHOLD NAMES" IN OUR FIELD. DURING THIS YEAR, WE DISCOVERED A NEW EVEN EARLIER STAGE OF AD, THE FIRST NEW STAGE OF AD IDENTIFIED IN THE PAST SEVERAL DECADES. A REPORT WAS DONE ON THIS STAGE, WHICH WE TERMED, "PSYCHOMETRIC COGNITIVE DECLINE." THIS STAGE PRECEDES THE ADVENT OF SCD. WE RECRUITED 60 HEALTHY PERSONS WITH, "NO COGNITIVE DECLINE." WE FOLLOWED 47 OF THESE PERSONS OVER A MEAN OF 6.7 YEARS. AT FOLLOW-UP, WE CLASSIFIED PERSONS AS DECLINERS IF THEY DEVELOPED SCD OR WORSE AND AS NON-DECLINERS IF THEY REMAINED FREE OF SUBJECTIVE OR OBJECTIVE IMPAIRMENTS. AT FOLLOW-UP, WE FOUND THAT THERE WAS A VERY SIGNIFICANT DIFFERENCE BETWEEN THE TWO GROUPS IN THE DECLINE RATE. AFTER CONTROLLING FOR DEMOGRAPHIC VARIABLES AND FOLLOW-UP TIME, OUR COMBINATORIAL PSYCHOMETRIC TEST SCORE WAS SIGNIFICANTLY LOWER IN THE FUTURE DECLINERS. THIS WAS THE FIRST STUDY TO LINK PSYCHOMETRIC COGNITIVE DECLINE TO EVENTUAL AD. THESE RESULTS WERE PUBLISHED AS A "30TH ANNIVERSARY RESEARCH ARTICLE" IN DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, IN MAY 2020. THESE FINDINGS PROVIDE AN OPPORTUNITY FOR INTERVENTION AT AN EARLIER POINT IN THE EVOLUTION OF EVENTUAL ALZHEIMER'S DISEASE THAN HAS PREVIOUSLY BEEN POSSIBLE. WE ALSO STUDIED THE EFFECT OF OUR COMPREHENSIVE, INDIVIDUALIZED PERSON-CENTERED MANAGEMENT PROGRAM (CI-PCM) ON ANTIDEPRESSANT USAGE IN COMMUNITY-RESIDING, ADVANCED AD PERSONS. WE FOUND THAT THE CI-PCM PERSONS HAD SIGNIFICANT DECREASES IN ANTIDEPRESSANT USAGE AND IN BEHAVIORAL SYMPTOMATOLOGY, AS WELL AS A RESOLUTION OF THEIR DEPRESSIVE SYMPTOMS. THE GROUP WHO RECEIVED USUAL COMMUNITY CARE (UCC) RECEIVED MORE ANTIDEPRESSANT MEDICATION AND PAID 4.2 TIMES MORE FOR ANTIDEPRESSANTS. UCC PERSONS HAD A WORSENING OF BOTH BEHAVIORAL DISTURBANCES AND DEPRESSIVE SYMPTOMS.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$150,000TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$150,000TotalOtherProgSrvcGrantAmt
Total Program Service Expenses$5,744,317TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntYes (1)BusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document11IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee4EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members12GoverningBodyVotingMembersCnt
Independent Voting Member11IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process Other0CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1LUCRETIA HOLDENBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone2129151328PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1FDR STATION PO BOX 220AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10150ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (14 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmt
BARRY R SLOANE
CHAIRMAN/TREASURER6.75Yes (X)Yes (X)$0$0$0
HOWARD LUTNICK
VICE CHAIR0.25Yes (X)Yes (X)$0$0$0
MARTIN EDELMAN
VICE CHAIR0.25Yes (X)Yes (X)$0$0$0
DAVID HW TURNER
SECRETARY1.00Yes (X)Yes (X)$0$0$0
DR MANNY ALVAREZ
TRUSTEE0.25Yes (X)$0$0$0
DR E RATCLIFFE ANDERSON JR
TRUSTEE0.10Yes (X)$0$0$0
GERRY BYRNE
TRUSTEE0.50Yes (X)$0$0$0
HADLEY FISHER
TRUSTEE0.50Yes (X)$0$0$0
BETSY GOTBAUM
TRUSTEE0.50Yes (X)$0$0$0
JAMES L NEDERLANDER
TRUSTEE0.25Yes (X)$0$0$0
RICHARD J SALEM
TRUSTEE0.50Yes (X)$0$0$0
DR MOSHE SHIKE
TRUSTEE0.25Yes (X)$0$0$0
LOIS WHITMAN-HESS
TRUSTEE (THRU MAR 2020))0.25Yes (X)$0$0$0
LUCRETIA HOLDEN
EXECUTIVE DIRECTOR40.00Yes (X)$213,126$0$17,383
FieldValueIRS element (for citing)
Total Reportable Comp From Org$213,126TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$17,383TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K1IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (2 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
ELITE ACCOUNTING SERVICES LLC
500 MAMARONECK AVEHARRISONNY10528BOOKKEEPING SERVICES$123,868
STAYWELL COMPANY LLC
800 TOWNSHIP LINE ROADYARDLEYPA19067MAGAZINE PUBLISHING$121,934
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K2CntrctRcvdGreaterThan100KCnt
Federated Campaigns$226,998FederatedCampaignsAmt
All Other Contributions$7,231,791AllOtherContributionsAmt
Noncash Contributions$430,439NoncashContributionsAmt
Total Contributions$7,458,789TotalContributionsAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$383,515TotalRevenueColumnAmt
Exclusion$383,515ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$5,760,042SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$3,607,040SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$2,153,002SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,153,002TotalRevenueColumnAmt
Exclusion$2,153,002ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescOTHER INCOMEDesc
Business900099BusinessCd
Total Revenue Column$385TotalRevenueColumnAmt
Exclusion$385ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$385OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$9,995,691TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$2,536,902ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$4,934,013TotalAmt
Program Services$4,934,013ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$25,000TotalAmt
Program Services$25,000ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$230,509TotalAmt
Program Services$172,882ProgramServicesAmt
Management And General$11,525ManagementAndGeneralAmt
Fundraising$46,102FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$289,424TotalAmt
Program Services$147,453ProgramServicesAmt
Management And General$47,811ManagementAndGeneralAmt
Fundraising$94,160FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$12,694TotalAmt
Program Services$7,323ProgramServicesAmt
Management And General$1,687ManagementAndGeneralAmt
Fundraising$3,684FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$20,130TotalAmt
Program Services$10,340ProgramServicesAmt
Management And General$3,285ManagementAndGeneralAmt
Fundraising$6,505FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$34,986TotalAmt
Program Services$21,393ProgramServicesAmt
Management And General$4,070ManagementAndGeneralAmt
Fundraising$9,523FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$12,392TotalAmt
Management And General$12,392ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$157,906TotalAmt
Management And General$157,906ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$73,575TotalAmt
Management And General$73,575ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$106,782TotalAmt
Program Services$18,919ProgramServicesAmt
Management And General$13,610ManagementAndGeneralAmt
Fundraising$74,253FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$71,640TotalAmt
Program Services$70,711ProgramServicesAmt
Management And General$76ManagementAndGeneralAmt
Fundraising$853FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$49,171TotalAmt
Program Services$16,121ProgramServicesAmt
Management And General$13,732ManagementAndGeneralAmt
Fundraising$19,318FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$4,014TotalAmt
Program Services$399ProgramServicesAmt
Management And General$3,223ManagementAndGeneralAmt
Fundraising$392FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$156,279TotalAmt
Program Services$30,508ProgramServicesAmt
Fundraising$125,771FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$3,586TotalAmt
Management And General$3,586ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,358TotalAmt
Management And General$1,232ManagementAndGeneralAmt
Fundraising$126FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$787TotalAmt
Management And General$787ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$1,670TotalAmt
Management And General$1,670ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
PRINTING AND PUBLISHING$286,356$286,356
PROCESSING FEES$90,138$90,138
DUES & SUBSCRIPTIONS$11,184$2,899$4,702$3,583
MISCELLANEOUS$3,152$3,152

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$164TotalAmt
Management And General$164ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$6,576,910TotalAmt
Program Services$5,744,317ProgramServicesAmt
Management And General$448,323ManagementAndGeneralAmt
Fundraising$384,270FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$4,148,305BOYAmt
EOY$4,063,644EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$9,016,767BOYAmt
EOY$8,272,054EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$517,434BOYAmt
EOY$672,687EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$5,107BOYAmt
EOY$4,976EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$6,979BOYAmt
EOY$15,016EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$12,806LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$10,728LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$2,865BOYAmt
EOY$2,078EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$17,821,738BOYAmt
EOY$21,767,434EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$2,765BOYAmt
EOY$1,861EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$31,521,960BOYAmt
EOY$34,799,750EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$79,748BOYAmt
EOY$240,532EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$2,810,985BOYAmt
EOY$2,204,998EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$2,890,733BOYAmt
EOY$2,445,530EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$28,326,376BOYAmt
EOY$32,129,483EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$304,851BOYAmt
EOY$224,737EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$28,631,227BOYAmt
EOY$32,354,220EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$31,521,960BOYAmt
EOY$34,799,750EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$3,418,781ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$304,212NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Info In Schedule O Part XIIYes (X)InfoInScheduleOPartXIIInd
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$4,377,975CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$6,064,311CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,365,421CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$6,868,429CurrentTaxYearMinus1YearAmt
Current Tax Year$7,458,789CurrentTaxYearAmt
Total$30,134,925TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$4,377,975CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$6,064,311CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,365,421CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$6,868,429CurrentTaxYearMinus1YearAmt
Current Tax Year$7,458,789CurrentTaxYearAmt
Total$30,134,925TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$1,468,040SubstantialContributorsTotAmt
Public Support Total170$28,666,885PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$350,202CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$331,693CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$324,830CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$480,283CurrentTaxYearMinus1YearAmt
Current Tax Year$383,515CurrentTaxYearAmt
Total$1,870,523TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,336CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,790CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$670CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$3,000CurrentTaxYearMinus1YearAmt
Current Tax Year$385CurrentTaxYearAmt
Total$7,181TotalAmt
FieldValueIRS element (for citing)
Total Support$32,012,629TotalSupportAmt
Gross Receipts Rltd Activities$412GrossReceiptsRltdActivitiesAmt
Public Support CY1700.89550PublicSupportCY170Pct
Public Support PY1700.87040PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME:FormAndLineReferenceDesc
ExplanationMISCELLANEOUS - 2016 AMOUNT: $ 1,336. 2017 AMOUNT: $ 1,790. 2018 AMOUNT: $ 670. 2019 AMOUNT: $ 3,000. 2020 AMOUNT: $ 385.ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$12,806OtherCostOrOtherBasisAmt
Depreciation$10,728DepreciationAmt
Book Value$2,078BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$2,078TotalBookValueLandBuildingsAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$10,537,766TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$304,212NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$311,438DonatedServicesAndUseFcltsAmt
Revenue Not Reported$615,650RevenueNotReportedAmt
Revenue Subtotal$9,922,116RevenueSubtotalAmt
Investment Expenses Not Incld$73,575InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$73,575RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$9,995,691TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$6,814,773TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$311,438DonatedServicesUseFcltsAmt
Expenses Not Reported$311,438ExpensesNotReportedAmt
Expenses Subtotal$6,503,335ExpensesSubtotalAmt
Investment Expenses Not Incld2$73,575InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt$73,575ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$6,576,910TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART X, LINE 2:FormAndLineReferenceDesc
ExplanationACCOUNTING FOR UNCERTAINTY IN INCOME TAXES - THE FOUNDATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE FOUNDATION HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. THE FOUNDATION IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR TAX YEARS PRIOR TO 2017.ExplanationTxt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp

FieldValueIRS element (for citing)
RegionEUROPERegionTxt
Offices0OfficesCnt
Employee0EmployeeCnt
Type Of Activities ConductedGRANTMAKINGTypeOfActivitiesConductedTxt
Region Total Expenditures$25,000RegionTotalExpendituresAmt
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$25,000SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$25,000TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp

FieldValueIRS element (for citing)
RegionEUROPERegionTxt
Purpose Of GrantALZHEIMER'S RESEARCHPurposeOfGrantTxt
Cash Grant$25,000CashGrantAmt
Manner Of Cash DisbursementWIRE TRANSFERMannerOfCashDisbursementTxt
FieldValueIRS element (for citing)
Total501c3 Org1Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 2:A SINGLE GRANT WAS GIVEN TO A RESEARCH INSTITUTE IN EUROPE FOR PROGRAM-RELATED RESEARCH. THE GRANTEE ORGANIZATION PROVIDED THE ORGANIZATION WITH MONTHLY REPORTS ON THE PROGRESS OF THEIR INVESTIGATIONS, AS WELL AS A FINAL REPORT AT THE END OF THE AGREEMENT.
PART I, LINE 3:THE ORGANIZATION USES THE ACCRUAL METHOD OF ACCOUNTING TO ACCOUNT FOR ITS FOREIGN EXPENDITURES.
PART III ACCOUNTING METHOD:

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (2 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
THE ROCKEFELLER UNIVERSITY
1230 YORK AVENUENEW YORKNY10021131624158501(C)(3)$4,750,000NEUROLOGICAL RESEARCH INTO THE CAUSES OF ALZHEIMER'S DISEASE, POTENTIAL NEW PHARMACOLOGICAL TREATMENT OPTIONS, PROFESSORSHIP TO CONDUCT RESEARCH ACTIVITIES, AND COVID-19 RESEARCH."
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
550 FIRST AVENUENEW YORKNY10016135562308501(C)(3)$125,000CLINICAL RESEARCH INTO THE EFFICACY OF MEMANTINE, AND COMPREHENSIVE INDIVIDUALIZED PATIENT-CENTERED MANAGEMENT OF ALZHEIMER'S DISEASE.
FieldValueIRS element (for citing)
Total501c3 Org2Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 2:THE FOUNDATION MONITORS THE USE OF GRANT FUNDS IN THE US BY RECEIVING PERIODIC PROGRESS REPORTS ON THE RESEARCH CONDUCTED AND ANY FINDINGS PUBLISHED AS A RESULT OF THIS FUNDING. THE FISHER CENTER FOR ALZHEIMER'S DISEASE RESEARCH AT THE ROCKEFELLER UNIVERSITY SUBMITS A REPORT AT EACH GENERAL BOARD MEETING WHICH IS INCORPORATED INTO THE MINUTES OF THE MEETING. THE FISHER EDUCATIONAL AND RESOURCES PROGRAM AT NYU SCHOOL OF MEDICINE REPORTS AT THE END OF THE FUNDING PERIOD IN THEIR REQUEST FOR FURTHER FUNDING ON THE PROGRESS TO DATE OF THE RESEARCH ACTIVITIES SUPPORTED BY THE FOUNDATION. THE FOUNDATION FUNDING DECISIONS ARE MADE UNDER THE SOLE AND ABSOLUTE DISCRETION OF THE BOARD PURSUANT TO A MAJORITY VOTE. A SCIENCE ADVISORY BOARD COMPRISED OF MEDICAL AND SCIENTIFIC EXPERTS IN THE FIELD OF ALZHEIMER'S DISEASE AND RELATED DISEASES ADVISES AND ASSISTS THE FOUNDATION IN CONNECTION WITH FUNDING GRANT REQUESTS.
FORM 990, SCHEDULE I, PART II, COLUMN (H):GRANTS TO THE ROCKEFELLER UNIVERSITY: THE GRANTEE PROVIDES PERIODIC PROGRESS REPORTS ON THE RESEARCH CONDUCTED AND ANY FINDINGS PUBLISHED, AND ALSO SUBMITS A REPORT FOR EACH GENERAL BOARD MEETING WHICH IS INCORPORATED INTO THE MINUTES OF THE MEETING. GRANT TO NYU MEDICAL CENTER: THE GRANTEE PROVIDES A REPORT AT THE END OF THE FUNDING PERIOD ON THE PROGRESS TO DATE OF THE RESEARCH ACTIVITIES.

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (1)AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp

FieldValueIRS element (for citing)
PersonLUCRETIA HOLDENPersonNm
TitleEXECUTIVE DIRECTORTitleTxt
Base Compensation Filing Org$163,126BaseCompensationFilingOrgAmt
Compensation Based On Rltd Orgs$0CompensationBasedOnRltdOrgsAmt
Bonus Filing Organization$50,000BonusFilingOrganizationAmount
Bonus Related Organizations$0BonusRelatedOrganizationsAmt
Other Compensation Filing Org$0OtherCompensationFilingOrgAmt
Other Compensation Rltd Orgs$0OtherCompensationRltdOrgsAmt
Deferred Compensation Flng Org$3,171DeferredCompensationFlngOrgAmt
Deferred Comp Rltd Orgs$0DeferredCompRltdOrgsAmt
Nontaxable Benefits Filing Org$14,212NontaxableBenefitsFilingOrgAmt
Nontaxable Benefits Rltd Orgs$0NontaxableBenefitsRltdOrgsAmt
Total Compensation Filing Org$230,509TotalCompensationFilingOrgAmt
Total Compensation Rltd Orgs$0TotalCompensationRltdOrgsAmt
Comp Report Prior990 Filing Org$0CompReportPrior990FilingOrgAmt
Comp Report Prior990 Rltd Orgs$0CompReportPrior990RltdOrgsAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 7FormAndLineReferenceDesc
ExplanationTHE EXECUTIVE DIRECTOR, LUCRETIA HOLDEN, WAS AWARDED A BONUS OF $50,000 BY A UNANIMOUS VOTE OF THE COMPENSATION COMMITTEE OF THE BOARD, WHICH IS REPORTED ON SCHEDULE J, PART II, COLUMN B(III).ExplanationTxt

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1CENTURY BANKBusinessNameLine1Txt
FieldValueIRS element (for citing)
Relationship DescriptionSEE PART VRelationshipDescriptionTxt
Transaction$6,650,029TransactionAmt
TransactionSEE PART VTransactionDesc
Sharing Of Revenues0SharingOfRevenuesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceFORM 990, SCHEDULE L, PART IVFormAndLineReferenceDesc
ExplanationRESULTING FROM HIGHLY COMPETITIVE RATES OFFERED BY CENTURY BANK, THE FOUNDATION HOLDS $6,650,029 IN CERTIFICATES OF DEPOSIT AND A MONEY MARKET ACCOUNT WITH CENTURY BANK, WHERE MR. BARRY SLOANE (THE FOUNDATION'S CHAIRMAN/TREASURER) SERVES AS PRESIDENT AND CEO. MR. BARRY SLOANE AND HIS FAMILY MEMBERS OWN MORE THAN 35% OF THE TOTAL COMBINED VOTING POWER OF CENTURY BANK. THE ENTIRE BOARD WAS MADE AWARE OF THE CONFLICT WITH MR. SLOANE BEFORE THE INVESTMENTS WERE MADE, AS WELL AS A CONTINUING DISCLOSURE AT ALL SUBSEQUENT BOARD MEETINGS. THE BOARD UNANIMOUSLY VOTED TO APPROVE THE INVESTMENTS. MR. SLOANE RECUSED HIMSELF FROM THE VOTE.ExplanationTxt

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution46ContributionCnt
Noncash Contributions Rpt F990$430,439NoncashContributionsRptF990Amt
Method Of Determining RevenuesAVG SELLING PRICEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (1)ReviewProcessUnusualNCGiftsInd
Third Parties Used0ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, COLUMN (B):FormAndLineReferenceDesc
ExplanationTHE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTIONS ON PART I, LINE 9, COLUMN (B).ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION B, LINE 11BTHE 990 IS INITIALLY REVIEWED BY MEMBERS OF THE AUDIT COMMITTEE THAT CONSISTS OF 3 INDEPENDENT TRUSTEES. A COPY IS THEN FORWARDED ELECTRONICALLY TO ALL BOARD MEMBERS AND RELEVANT MANAGEMENT PERSONNEL FOR THEIR REVIEW AND COMMENT. ANY REQUIRED REVISIONS ARE MADE AND THE REVISED 990 IS RESUBMITTED TO ALL BOARD MEMBERS FOR FINAL REVIEW BEFORE FILING.
FORM 990, PART VI, SECTION B, LINE 12CTHE FOUNDATION HAS A CONFLICT OF INTEREST POLICY WHICH IS ANNUALLY MONITORED REQUIRING ALL TRUSTEES TO DISCLOSE ANY POSSIBLE CONFLICT OF INTEREST VIA EMAIL RESPONSE TO THE EXECUTIVE DIRECTOR. THE FOUNDATION REQUIRES THAT ALL TRUSTEES, OFFICERS, KEY EMPLOYEES AND STAFF PERSONNEL PROMPTLY AND FULLY DISCLOSE ALL MATERIAL FACTS OF ANY ACTUAL OR POTENTIAL CONFLICT OF INTEREST THAT MAY EXIST AT THE TIME THE TRUSTEE IS APPOINTED OR STAFF PERSONNEL IS HIRED, OR AS THEY MAY ARISE WHILE THE TRUSTEE IS SERVING ON THE BOARD OR THE STAFF PERSONNEL IS EMPLOYED BY THE FOUNDATION. SUCH DISCLOSURES INVOLVING A TRANSACTION, ARRANGEMENT OR DECISION BEING CONSIDERED BY THE BOARD ARE MADE KNOWN TO ALL TRUSTEES. THE BOARD THEN DETERMINES WHETHER A CONFLICT OF INTEREST EXISTS WITH THE INTERESTED PARTY ABSTAINING FROM THE DECISION. IF IT IS DETERMINED THAT NO CONFLICT EXISTS, THEN THE BOARD VOTES ON THE TRANSACTION BUT WITH THE INTERESTED PARTY RECUSING HIMSELF FROM THE DISCUSSION AND VOTE ON SAID MATTER.
FORM 990, PART VI, SECTION B, LINE 15ATHE FOUNDATION HAS A COMPENSATION COMMITTEE CONSISTING OF 3 INDEPENDENT TRUSTEES TO DETERMINE THE COMPENSATION OF TOP MANAGEMENT AND KEY EMPLOYEES AT LEAST ONCE A YEAR. THE COMMITTEE IS MANDATED BY ITS CHARTER TO REVIEW EXECUTIVE AND OTHER KEY EMPLOYEE PERFORMANCE CONSISTENT WITH THE GOALS AND OBJECTIVES OF THE FOUNDATION AS DETERMINED BY THE BOARD OF TRUSTEES, AND TO DETERMINE AN APPROPRIATE LEVEL OF COMPENSATION IN LIGHT OF THIS PERFORMANCE REVIEW AND USING OTHER SUBSTANTIATING DATA SURVEYS ON CURRENT COMPENSATION RATES FOR SIMILAR POSITIONS IN OTHER COMPARABLE NONPROFITS IN THE NEW YORK CITY AREA. THE COMMITTEE'S DECISION IS DOCUMENTED IN A CONTEMPORANEOUSLY WRITTEN FORMAT (COMPENSATION COMMITTEE MINUTES) INDICATING THE DATE OF THE MEETING, THE MEMBERS PRESENT, AND THE COMPARABLE DATA USED TO MAKE THE DECISION. THE COMPENSATION REVIEW PROCESS FOR THE EXECUTIVE DIRECTOR WAS LAST UNDERTAKEN IN DECEMBER 2020.
FORM 990, PART VI, SECTION C, LINE 19THE FOUNDATION MAKES ITS FORM 990 AND AUDITED FINANCIAL STATEMENTS AVAILABLE FOR PUBLIC INSPECTION BY POSTING IT ON THEIR WEBSITE. THE FORM 990 IS AVAILABLE ON OTHER WEBSITES, SUCH AS WWW.GUIDESTAR.ORG. IN ADDITION, GOVERNING DOCUMENTS, THE FORM 990, AUDITED FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND OTHER POLICIES ARE AVAILABLE UPON WRITTEN REQUEST AT FDR STATION, P.O. BOX 220, NEW YORK NY 10150 OR BY CALLING THE ORGANIZATION DIRECTLY AT (800) 259-4636 OR (212) 915-1328.
FORM 990, PART XII, LINE 2C:THE FOUNDATION HAS AN AUDIT COMMITTEE THAT IS RESPONSIBLE FOR THE OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND THE SELECTION OF AN INDEPENDENT ACCOUNTANT. THE PROCESS HAS NOT CHANGED FROM THE PREVIOUS YEAR.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.